The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Dobrin Vassilev
Showing 1-7 of 7 articles
Regular drug-eluting stents versus dedicated bifurcation drug-eluting BiOSS stents for coronary bifurcation treatment: four-year results of the randomised POLBOS I and POLBOS II clinical trials
Gil R,
Bil J,
Kern A,
Ingio Garcia L,
Formuszewicz R,
Dobrzycki S,
Vassilev D,
Segiet A
March 20, 2020 | 10.4244/EIJ-D-18-00172
Intracoronary electrocardiogram to guide percutaneous interventions in coronary bifurcations – a proof of concept: the FIESTA (Ffr vs. IcEcgSTA) study
Vassilev D,
Dosev L,
Collet C,
Karamfiloff K,
Stoikova J,
Pancheva R,
Shumkova M,
Zlatancheva G,
Naunov V,
Rigatelli G,
Kassab G,
Gil R,
Serruys P
August 3, 2018 | 10.4244/EIJ-D-17-00189
Regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM® stent: the randomised, multicentre, open-label, controlled POLBOS II trial
Gil R,
Bil J,
Grundeken M.J,
Kern A,
Iñigo Garcia L,
Vassilev D,
Pawłowski T,
Formuszewicz R,
Dobrzycki S,
Wykrzykowska JJ,
Serruys P
December 9, 2016 | 10.4244/EIJY15M11_11
Long-term effectiveness and safety of the sirolimus-eluting BiOSS LIM® dedicated bifurcation stent in the treatment of distal left main stenosis: an international registry
Gil R,
Bil J,
Grundeken M.J,
Iñigo Garcia L,
Vassilev D,
Kern A,
Pawłowski T,
Wykrzykowska JJ,
Serruys P
November 20, 2016 | 10.4244/EIJY15M10_05
The BiOSS stent
Gil R,
Bil J,
Vassilev D
May 19, 2015 | 10.4244/EIJV11SVA37
Dedicated paclitaxel-eluting bifurcation stent BiOSS® (bifurcation optimisation stent system): 12-month results from a prospective registry of consecutive all-comers population
Gil R,
Vassilev D,
Michalek A,
Kern A,
Formuszewicz R,
Dobrzycki S,
Wójcik J,
Lesiak M,
Kardaszewicz P,
Lekston A
July 27, 2012 | 10.4244/EIJV8I3A50
Bifurcation Optimisation Stent System (BiOSS Lim) with sirolimus elution: results from porcine coronary artery model
Vassilev D,
Gil R,
Milewski K
September 30, 2011 | 10.4244/EIJV7I5A98
1
Latest news
AHEAD OF PRINT
Extracardiac basal annuloplasty for the treatment of secondary mitral regurgitation
FREE ARTICLE - Jérémy Bernard et al
August 11, 2022
AHEAD OF PRINT
LVOT calcification in TAVI : a post hoc analysis from the SOLVE-TAVI trial
FREE ARTICLE - Serdar Farhan et al
August 9, 2022
NEW ISSUE
The 16th EBC Expert consensus; ticagrelor or aspirin monotherapy 1 year after PCI; vasospasm and atherosclerosis in ANOCA; lifetime valve journey; and more…
August 5, 2022
AHEAD OF PRINT
RADIANCE-HTN SOLO 36-month analysis
FREE ARTICLE - Florian Rader et al
August 1, 2022
AHEAD OF PRINT
Percutaneous left atrial appendage closure with superior vascular access
FREE ARTICLE - Roberto Galea et al
August 4, 2022
AHEAD OF PRINT
Dual ProGlide vs ProGlide and FemoSeal after TAVI
FREE ARTICLE - Jonas M.D. Gmeiner et al
July 29, 2022
AHEAD OF PRINT
Stent thrombosis in comatose OHCA (ST-OHCA Study)
FREE ARTICLE - Martin Rauber et al
July 25, 2022
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke